الدليل الوطني للأدوية المسجّلة في لبنان
تحتوي هذه الفقرة على المعلومات الخاصة بالمستحضرات الصيدلانية المسجّلة في وزارة الصحة العامة وهي المرجع الرسمي الوحيد لقاعدة بيانات الأدوية المسموح لتسويقها في لبنان
يمكنكم البحث أدناه عن المعلومات الرسمية للأدوية المسجّلة بالاضافة الى نسبة الدعم
الأدوية التي ليها رمز ينتهي ب "945/" تخضع للقرار رقم 1/945 تاريخ 3/10/2022
| رمز التصنيف العلاجي الصيدلاني (ATC) | الإسم | ب / ج | المكونات | الجرعة | الشكل | السعر |
|---|---|---|---|---|---|---|
| C01BC04 | FLECAINIDE BIOGARAN L.P. | G | Flecainide acetate - 100mg | 100mg | Capsule, extended release | 1154360.7075 |
| C01BC04 | FLECAINIDE BIOGARAN L.P. | G | Flecainide acetate - 50mg | 50mg | Capsule, extended release | 1154360.7075 |
| C01BC03 | RYTMONORM | B | Propafenone HCl - 150mg | 150mg | Tablet, film coated | 1119849.848117 |
| C01BC03 | RYTMONORM | B | Propafenone HCl - 300mg | 300mg | Tablet, film coated | 1883859.55758 |
| C01AA05 | LANOXIN PG | B | Digoxin - 0.05mg/ml | 0.05mg/ml | Elixir | 307739.9325 |
| C01AA05 | LANOXIN | B | Digoxin - 0.25mg | 0.25mg | Tablet | 215014.8 |
| B06AC05 | TAKHZYRO | BioTech | Lanadelumab - 300mg/2ml | 300mg | Injectable solution | 1202366121.2062 |
| B06AC05 | TAKHZYRO | BioTech | Lanadelumab - 300mg/2ml | Injectable solution | 1204227926.8884 | |
| B06AC05 | TAKHZYRO | BioTech | Lanadelumab - 300mg/2ml | 300mg | Injectable solution | |
| B05ZA | CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE C | G | Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.33g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 204.54g/l | Injectable solution | ||
| B05ZA | CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE D | G | Potassium chloride - 5.215g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l | Injectable solution | ||
| B05ZA | CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE E | G | Potassium chloride - 2.611g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 7.00g/l, Sodium acetate, 3H2O - 190.505g/l, Sodium chloride - 205.49g/l | Injectable solution | ||
| B05ZA | CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE F | G | Potassium chloride - 3.914g/l, Magnesium chloride, 6H2O - 3.558g/l, Calcium chloride, 2H2O - 7.719g/l, Acetic acid 100% - 6.010ml/l, Sodium chloride - 208.631g/l | Injectable solution | ||
| B05ZA | CONCENTRATE SOLUTION FOR HEMODIALYSIS TYPE SG | G | Potassium chloride - 3.92g/l, Magnesium chloride, 6H2O - 5.32g/l, Calcium chloride, 2H2O - 8.99g/l, Sodium acetate, 3H2O - 166.7g/l, Sodium chloride - 214.76g/l | Injectable solution | ||
| B05ZA | CONCENTRATE SOLUTION FOR HEMODIALYSIS L | G | Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:106.5 mmol/l, Sodium chloride - Na+:135 mmol/l | Injectable solution | ||
| B05ZA | CONCENTRATE SOLUTION FOR HEMODIALYSIS LM | G | Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l | Injectable solution |